GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Doseology Sciences Inc (OTCPK:DOSEF) » Definitions » Net-Net Working Capital

DOSEF (Doseology Sciences) Net-Net Working Capital : $0.13 (As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Doseology Sciences Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Doseology Sciences's Net-Net Working Capital for the quarter that ended in Mar. 2025 was $0.13.

The industry rank for Doseology Sciences's Net-Net Working Capital or its related term are showing as below:

DOSEF's Price-to-Net-Net-Working-Capital is ranked worse than
52.1% of 879 companies
in the Biotechnology industry
Industry Median: 4.05 vs DOSEF: 4.38

Doseology Sciences Net-Net Working Capital Historical Data

The historical data trend for Doseology Sciences's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Doseology Sciences Net-Net Working Capital Chart

Doseology Sciences Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24
Net-Net Working Capital
0.05 0.08 0.19 0.22 0.17

Doseology Sciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.17 0.16 0.14 0.13

Competitive Comparison of Doseology Sciences's Net-Net Working Capital

For the Biotechnology subindustry, Doseology Sciences's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Doseology Sciences's Price-to-Net-Net-Working-Capital Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Doseology Sciences's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Doseology Sciences's Price-to-Net-Net-Working-Capital falls into.


;
;

Doseology Sciences Net-Net Working Capital Calculation

Doseology Sciences's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Jun. 2024 is calculated as

Net-Net Working Capital(A: Jun. 2024 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.773+0.75 * 0.001+0.5 * 0.029-0.06
-0-0)/4.401
=0.17

Doseology Sciences's Net-Net Working Capital (NNWC) per share for the quarter that ended in Mar. 2025 is calculated as

Net-Net Working Capital(Q: Mar. 2025 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.571+0.75 * 0.02+0.5 * 0.012-0.021
-0-0)/4.501
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Doseology Sciences  (OTCPK:DOSEF) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Doseology Sciences Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Doseology Sciences's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Doseology Sciences Business Description

Traded in Other Exchanges
Address
9-3151 Lakeshore Road, Suite 305, Kelowna, BC, CAN, V1W 3S9
Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. Doseology offers cutting-edge therapeutic products and services, with the focus of making a meaningful impact on the mental health pandemic and improving overall health. Geographically earns it revenue from Canada.

Doseology Sciences Headlines

From GuruFocus

Doseology Opens to American Investors

By PRNewswire PRNewswire 06-21-2022

Doseology Welcomes New CFO

By PRNewswire PRNewswire 03-03-2023

Doseology Opens to American Investors

By PRNewswire PRNewswire 07-11-2022

Doseology Opens to American Investors

By PRNewswire PRNewswire 07-01-2022

Doseology Uplists to OTCQB Market in USA

By PRNewswire PRNewswire 07-06-2022

Doseology Announces CEO Transition

By PRNewswire PRNewswire 03-31-2023

Doseology Opens to American Investors

By PRNewswire PRNewswire 06-11-2022

Doseology Provides Corporate Update

By PRNewswire PRNewswire 01-23-2023

Doseology Announces New Director and Corporate Secretary

By PRNewswire PRNewswire 05-05-2023